Monica Albaladejo-Belmonte
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Monica Albaladejo-Belmonte has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Javier Garcia-Casado
Centro de Investigación e Innovación en Bioingeniería (CI2B), Universitat Politècnica de València, 46022 Valencia, Spain
10 shared publications - Francisco Jose Nohales Alfonso
Servicio de Ginecología y Obstetricia, Hospital Politècnic i Universitari La Fe, 46026 Valencia, Spain
4 shared publications - Maria De-Arriba
Hospital Universitario y Politécnico La Fe Valencia Spain
4 shared publications - Marta Tarazona-Motes
Servicio de Ginecología y Obstetricia, Hospital Politècnic i Universitari La Fe, 46026 Valencia, Spain
4 shared publications - Jose Alberola-Rubio
Unidad de Bioelectrónica, Procesamiento de señales y Algoritmia, Instituto de Investigación Sanitaria La Fe, 46026 Valencia, Spain
3 shared publications Francisco Jose Nohales-Alfonso
Servicio de Obstetricia y Ginecología, Hospital Universitario y Politécnico La Fe de Valencia , 46026 Valencia
2 shared publications
Latest Publications
- Open Access
- 21 May 2026
- Published by Elsevier in Biomedical Signal Processing and Control
- Vol. 123
Assessment of uterine slow wave coupling from multichannel surface electrohysterography to determine labor proximity
- 21 May 2026
- Published by Elsevier in Biomedical Signal Processing and Control
- Vol. 123
Open AccessAssessment of uterine slow wave coupling from multichannel surface electrohysterography to determine labor proximity
- Open Access
- 20 July 2025
- Published by Oxford University Press (OUP) in The Journal of Sexual Medicine
- Vol. 22 (9) , 1594-1603
Novel insights of vulvodynia pathophysiology from reliable and comprehensive pelvic floor muscle surface electromyography characterization: can it help predict response to botulinum toxin treatment?
Background: Findings on vulvodynia-associated alterations in the pelvic floor muscles’ (PFMs’) myoelectrical activity are contradictory, and no study has yet assessed whether they influence treatment outcomes. Aim: To characterize vulvodynia-associated alterations in PFM activity and assess its potential to predict the response to botulinum toxin type A (BoNT/A) treatment. Methods: This prospective, non-masked, and non-randomized study recruited 35 vulvodynia patients who underwent BoNT/A injections and 35 healthy women. Their left and right PFM activity was monitored by surface electromyography (sEMG) with 2 recording modalities (intravaginal probe and external electrodes) during PFM contractions and rest and compared across groups at baseline. Clinical information was also collected from their medical history, pelvic physical examination, and self-informed clinical questionnaires. Both sEMG and clinical features were used to predict the patient’s response to treatment using multiple binary logistic regression models. Outcomes: sEMG signals’ root mean square (RMS), median frequency (MDF), sample entropy (SampEn), intramuscular and intermuscular magnitude-squared coherence (mscoh) and imaginary part of their coherency (iCOH), and clinical outcomes (sociodemographic, obstetric, gynecological, urological, and other general clinical characteristics; painful comorbidities; pelvic and vulvar pain sensitivity; Patient’s Global Impression of Improvement). Results: Vulvodynia patients exhibited significantly lower intensity during contractions (mscoh) during contractions (P = .004) and rest (P = .006) in the myoelectrical activity of their left superficial PFM (sEMG from external electrodes) and altered intermuscular coupling during contractions (>mscoh, P = .004) in their deep PFM (sEMG from intravaginal probe) than healthy women. Furthermore, intramuscular coupling at rest was significantly associated with response to treatment (P < .01) and predicted it accurately when combined with clinical information (AUC = 0.95). Clinical Implications: PFM sEMG can provide valuable insights into vulvodynia pathophysiology and help optimize treatment selection, potentially reducing the economic and psychological impact of ineffective treatment. Strengths and Limitations: This study provides a reliable and comprehensive description of PFM myoelectrical activity alterations in vulvodynia conditions, demonstrating for the first time that sEMG information can improve the prediction of treatment response. It is limited by a small sample size of intravaginal probe recordings due to pain elicited by probes during their insertion and signal quality. Conclusion: Vulvodynia is associated with decreased activity intensity in the superficial PFM and altered electrical coupling, as shown by sEMG, which can enhance the precision of BoNT/A treatment response prediction and thus reduce the economic and psychological burden of ineffective treatment.
- 20 July 2025
- Published by Oxford University Press (OUP) in The Journal of Sexual Medicine
- Vol. 22 (9) , 1594-1603
Open AccessNovel insights of vulvodynia pathophysiology from reliable and comprehensive pelvic floor muscle surface electromyography characterization: can it help predict response to botulinum toxin treatment?
Background: Findings on vulvodynia-associated alterations in the pelvic floor muscles’ (PFMs’) myoelectrical activity are contradictory, and no study has yet assessed whether they influence treatment outcomes. Aim: To characterize vulvodynia-associated alterations in PFM activity and assess its potential to predict the response to botulinum toxin type A (BoNT/A) treatment. Methods: This prospective, non-masked, and non-randomized study recruited 35 vulvodynia patients who underwent BoNT/A injections and 35 healthy women. Their left and right PFM activity was monitored by surface electromyography (sEMG) with 2 recording modalities (intravaginal probe and external electrodes) during PFM contractions and rest and compared across groups at baseline. Clinical information was also collected from their medical history, pelvic physical examination, and self-informed clinical questionnaires. Both sEMG and clinical features were used to predict the patient’s response to treatment using multiple binary logistic regression models. Outcomes: sEMG signals’ root mean square (RMS), median frequency (MDF), sample entropy (SampEn), intramuscular and intermuscular magnitude-squared coherence (mscoh) and imaginary part of their coherency (iCOH), and clinical outcomes (sociodemographic, obstetric, gynecological, urological, and other general clinical characteristics; painful comorbidities; pelvic and vulvar pain sensitivity; Patient’s Global Impression of Improvement). Results: Vulvodynia patients exhibited significantly lower intensity during contractions (mscoh) during contractions (P = .004) and rest (P = .006) in the myoelectrical activity of their left superficial PFM (sEMG from external electrodes) and altered intermuscular coupling during contractions (>mscoh, P = .004) in their deep PFM (sEMG from intravaginal probe) than healthy women. Furthermore, intramuscular coupling at rest was significantly associated with response to treatment (P < .01) and predicted it accurately when combined with clinical information (AUC = 0.95). Clinical Implications: PFM sEMG can provide valuable insights into vulvodynia pathophysiology and help optimize treatment selection, potentially reducing the economic and psychological impact of ineffective treatment. Strengths and Limitations: This study provides a reliable and comprehensive description of PFM myoelectrical activity alterations in vulvodynia conditions, demonstrating for the first time that sEMG information can improve the prediction of treatment response. It is limited by a small sample size of intravaginal probe recordings due to pain elicited by probes during their insertion and signal quality. Conclusion: Vulvodynia is associated with decreased activity intensity in the superficial PFM and altered electrical coupling, as shown by sEMG, which can enhance the precision of BoNT/A treatment response prediction and thus reduce the economic and psychological burden of ineffective treatment.
- Open Access
Does Muscle Pain Induce Alterations in the Pelvic Floor Motor Unit Activity Properties in Interstitial Cystitis/Bladder Pain Syndrome? A High-Density sEMG-Based Study
Several studies have shown interstitial cystitis/bladder pain syndrome (IC/BPS), a chronic condition that poses challenges in both diagnosis and treatment, is associated with painful pelvic floor muscles (PFM) and altered neural drive to these muscles. However, its pathophysiology could also involve other alterations in the electrical activity of PFM motor units (MUs). Studying these alterations could provide novel insights into IC/BPS and help its clinical management. This study aimed to characterize PFM activity at the MU level in women with IC/BPS and pelvic floor myalgia using high-density surface electromyography (HD-sEMG). Signals were recorded from 15 patients and 15 healthy controls and decomposed into MU action potential (MUAP) spike trains. MUAP amplitude, firing rate, and magnitude-squared coherence between spike trains were compared across groups. Results showed that MUAPs had significantly lower amplitudes during contractions on the patients’ left PFM, and delta-band coherence was significantly higher at rest on their right PFM compared to controls. These findings suggest altered PFM tissue and neuromuscular control in women with IC/BPS and pelvic floor myalgia. Our results demonstrate that HD-sEMG can provide novel insights into IC/BPS-related PFM dysfunction and biomarkers that help identify subgroups of IC/BPS patients, which may aid their diagnosis and treatment.
Open AccessDoes Muscle Pain Induce Alterations in the Pelvic Floor Motor Unit Activity Properties in Interstitial Cystitis/Bladder Pain Syndrome? A High-Density sEMG-Based Study
Several studies have shown interstitial cystitis/bladder pain syndrome (IC/BPS), a chronic condition that poses challenges in both diagnosis and treatment, is associated with painful pelvic floor muscles (PFM) and altered neural drive to these muscles. However, its pathophysiology could also involve other alterations in the electrical activity of PFM motor units (MUs). Studying these alterations could provide novel insights into IC/BPS and help its clinical management. This study aimed to characterize PFM activity at the MU level in women with IC/BPS and pelvic floor myalgia using high-density surface electromyography (HD-sEMG). Signals were recorded from 15 patients and 15 healthy controls and decomposed into MU action potential (MUAP) spike trains. MUAP amplitude, firing rate, and magnitude-squared coherence between spike trains were compared across groups. Results showed that MUAPs had significantly lower amplitudes during contractions on the patients’ left PFM, and delta-band coherence was significantly higher at rest on their right PFM compared to controls. These findings suggest altered PFM tissue and neuromuscular control in women with IC/BPS and pelvic floor myalgia. Our results demonstrate that HD-sEMG can provide novel insights into IC/BPS-related PFM dysfunction and biomarkers that help identify subgroups of IC/BPS patients, which may aid their diagnosis and treatment.
- Open Access
- 11 October 2024
- Published by Elsevier in Journal of Electromyography and Kinesiology
- Vol. 79, 102940
Pelvic floor muscle electrical coupling in chronic pelvic pain: Insights into pathophysiology and botulinum toxin treatment effects
- 11 October 2024
- Published by Elsevier in Journal of Electromyography and Kinesiology
- Vol. 79, 102940
Open AccessPelvic floor muscle electrical coupling in chronic pelvic pain: Insights into pathophysiology and botulinum toxin treatment effects
- Open Access
Treatment of Vestibulodynia with Submucosal Injections of IncobotulinumtoxinA into Targeted Painful Points: An Open-Label Exploratory Study
The studies carried out to date on vulvodynia treatment with botulinum neurotoxin type A (BoNT/A) have followed generic injection protocols and reported contradictory outcomes on its effects. The aim of the present study was thus to propose a protocol for injecting BoNT/A into targeted painful points, to comprehensively assess the clinical effect of BoNT/A treatment and identify the risk/protective factors for successful treatment. Thirty-five vestibulodynia patients were treated with submucosal injections of incobotulinumtoxinA and assessed 8, 12 and 24 weeks after their treatment. Their clinical and pelvic statuses were assessed from self-reported questionnaires (Visual Analogue Scale (VAS), Female Sexual Function Index (FSFI), Marinoff’s Dyspareunia Scale (MDS), Hospital Anxiety and Depression Scale (HADS), Catastrophizing Scale (CS)), physical examinations and surface electromyography (sEMG). The patients reported a reduction in provoked vestibulodynia (p < 0.01), improved sexual function (>FSFI, p < 0.01; p = 0.01) and psychological status (p < 0.01), and lower pelvic floor hyperactivity at rest (p = 0.01). Factors such as smoking, painful comorbidities, vulvar pain sensitivity and sexual function were significantly associated with successful treatment. The results indicate the beneficial effects of BoNT/A in treating vestibulodynia and reinforce the importance of adapting the treatment according to its clinical presentation and the patient’s medical background.
Open AccessTreatment of Vestibulodynia with Submucosal Injections of IncobotulinumtoxinA into Targeted Painful Points: An Open-Label Exploratory Study
The studies carried out to date on vulvodynia treatment with botulinum neurotoxin type A (BoNT/A) have followed generic injection protocols and reported contradictory outcomes on its effects. The aim of the present study was thus to propose a protocol for injecting BoNT/A into targeted painful points, to comprehensively assess the clinical effect of BoNT/A treatment and identify the risk/protective factors for successful treatment. Thirty-five vestibulodynia patients were treated with submucosal injections of incobotulinumtoxinA and assessed 8, 12 and 24 weeks after their treatment. Their clinical and pelvic statuses were assessed from self-reported questionnaires (Visual Analogue Scale (VAS), Female Sexual Function Index (FSFI), Marinoff’s Dyspareunia Scale (MDS), Hospital Anxiety and Depression Scale (HADS), Catastrophizing Scale (CS)), physical examinations and surface electromyography (sEMG). The patients reported a reduction in provoked vestibulodynia (p < 0.01), improved sexual function (>FSFI, p < 0.01; p = 0.01) and psychological status (p < 0.01), and lower pelvic floor hyperactivity at rest (p = 0.01). Factors such as smoking, painful comorbidities, vulvar pain sensitivity and sexual function were significantly associated with successful treatment. The results indicate the beneficial effects of BoNT/A in treating vestibulodynia and reinforce the importance of adapting the treatment according to its clinical presentation and the patient’s medical background.
- 19 August 2022
- Published by IOP Publishing in Physiological Measurement
- Vol. 43 (8) , 085005
Uterine slow wave: directionality and changes with imminent delivery
Objective. The slow wave (SW) of the electrohysterogram (EHG) may contain relevant information on the electrophysiological condition of the uterus throughout pregnancy and labor. Our aim was to assess differences in the SW as regards the imminence of labor and the directionality of uterine myoelectrical activity. Approach . The SW of the EHG was extracted from the signals of the Icelandic 16-electrode EHG database in the bandwidth [5, 30] mHz and its power, spectral content, complexity and synchronization between the horizontal (X) and vertical (Y) directions were characterized by the root mean square (RMS), dominant frequency (domF), sample entropy (SampEn) and maximum cross-correlation (CCmax) of the signals, respectively. Significant differences between parameters at time-to-delivery (TTD) ≤7 versus >7 days and between the horizontal versus vertical directions were assessed. Main results. The SW power significantly increased in both directions as labor approached (TTD ≤ 7d versus >7d (mean±SD): R M S x = 0.12 ± 0.10 versus 0.08 ± 0.06 mV; R M S y = 0.12 ± 0.09 versus 0.08 ± 0.05 mV), as well as the dominant frequency in the horizontal direction ( d o m F x = 9.1 ± 1.3 versus 8.5 ± 1.2mHz) and the synchronization between both directions ( C C max = 0.44 ± 0.16 versus 0.36 ± 0.14). Furthermore, its complexity decreased in the vertical direction ( S a m p E n y = 6.13·10 −2 ± 8.7·10 −3 versus 6.50·10 −2 ± 8.3·10 −3) , suggesting a higher cell-to-cell electrical coupling. Whereas there were no differences between the SW features in both directions in the general population, statistically significant differences were obtained between them in individuals in many cases. Significance. Our results suggest that the SW of the EHG is related to bioelectrical events in the uterus and could provide objective information to clinicians in challenging obstetric scenarios.
- 19 August 2022
- Published by IOP Publishing in Physiological Measurement
- Vol. 43 (8) , 085005
Uterine slow wave: directionality and changes with imminent delivery
Objective. The slow wave (SW) of the electrohysterogram (EHG) may contain relevant information on the electrophysiological condition of the uterus throughout pregnancy and labor. Our aim was to assess differences in the SW as regards the imminence of labor and the directionality of uterine myoelectrical activity. Approach . The SW of the EHG was extracted from the signals of the Icelandic 16-electrode EHG database in the bandwidth [5, 30] mHz and its power, spectral content, complexity and synchronization between the horizontal (X) and vertical (Y) directions were characterized by the root mean square (RMS), dominant frequency (domF), sample entropy (SampEn) and maximum cross-correlation (CCmax) of the signals, respectively. Significant differences between parameters at time-to-delivery (TTD) ≤7 versus >7 days and between the horizontal versus vertical directions were assessed. Main results. The SW power significantly increased in both directions as labor approached (TTD ≤ 7d versus >7d (mean±SD): R M S x = 0.12 ± 0.10 versus 0.08 ± 0.06 mV; R M S y = 0.12 ± 0.09 versus 0.08 ± 0.05 mV), as well as the dominant frequency in the horizontal direction ( d o m F x = 9.1 ± 1.3 versus 8.5 ± 1.2mHz) and the synchronization between both directions ( C C max = 0.44 ± 0.16 versus 0.36 ± 0.14). Furthermore, its complexity decreased in the vertical direction ( S a m p E n y = 6.13·10 −2 ± 8.7·10 −3 versus 6.50·10 −2 ± 8.3·10 −3) , suggesting a higher cell-to-cell electrical coupling. Whereas there were no differences between the SW features in both directions in the general population, statistically significant differences were obtained between them in individuals in many cases. Significance. Our results suggest that the SW of the EHG is related to bioelectrical events in the uterus and could provide objective information to clinicians in challenging obstetric scenarios.
- Open Access
- 20 August 2021
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 18 (16) , 8783
Treatment of Dyspareunia with Botulinum Neurotoxin Type A: Clinical Improvement and Influence of Patients’ Characteristics
The treatment of chronic pelvic pain (CPP) with botulinum neurotoxin type A (BoNT/A) has increased lately, but more studies assessing its effect are needed. This study aimed to evaluate the evolution of patients after BoNT/A infiltration and identify potential responders to treatment. Twenty-four women with CPP associated with dyspareunia were treated with 90 units of BoNT/A injected into their pelvic floor muscle (PFM). Clinical status and PFM activity were monitored in a previous visit (PV) and 12 and 24 weeks after the infiltration (W12, W24) by validated clinical questionnaires and surface electromyography (sEMG). The influence of patients’ characteristics on the reduction in pain at W12 and W24 was also assessed. After treatment, pain scores and the impact of symptoms on quality of life dropped significantly, sexual function improved and sEMG signal amplitude decreased on both sides of the PFM with no adverse events. Headaches and bilateral pelvic pain were risk factors for a smaller pain improvement at W24, while lower back pain was a protective factor. Apart from reporting a significant clinical improvement of patients with CPP associated with dyspareunia after BoNT/A infiltration, this study shows that clinical characteristics should be analyzed in detail to identify potential responders to treatment.
- 20 August 2021
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 18 (16) , 8783
Open AccessTreatment of Dyspareunia with Botulinum Neurotoxin Type A: Clinical Improvement and Influence of Patients’ Characteristics
The treatment of chronic pelvic pain (CPP) with botulinum neurotoxin type A (BoNT/A) has increased lately, but more studies assessing its effect are needed. This study aimed to evaluate the evolution of patients after BoNT/A infiltration and identify potential responders to treatment. Twenty-four women with CPP associated with dyspareunia were treated with 90 units of BoNT/A injected into their pelvic floor muscle (PFM). Clinical status and PFM activity were monitored in a previous visit (PV) and 12 and 24 weeks after the infiltration (W12, W24) by validated clinical questionnaires and surface electromyography (sEMG). The influence of patients’ characteristics on the reduction in pain at W12 and W24 was also assessed. After treatment, pain scores and the impact of symptoms on quality of life dropped significantly, sexual function improved and sEMG signal amplitude decreased on both sides of the PFM with no adverse events. Headaches and bilateral pelvic pain were risk factors for a smaller pain improvement at W24, while lower back pain was a protective factor. Apart from reporting a significant clinical improvement of patients with CPP associated with dyspareunia after BoNT/A infiltration, this study shows that clinical characteristics should be analyzed in detail to identify potential responders to treatment.
- Open Access
Effect of BoNT/A in the Surface Electromyographic Characteristics of the Pelvic Floor Muscles for the Treatment of Chronic Pelvic Pain
Chronic pelvic pain (CPP) is a complex condition with a high economic and social burden. Although it is usually treated with botulinum neurotoxin type A (BoNT/A) injected into the pelvic floor muscles (PFM), its effect on their electrophysiological condition is unknown. In this study, 24 CPP patients were treated with BoNT/A. Surface electromyographic signals (sEMG) were recorded at Weeks 0 (infiltration), 8, 12 and 24 from the infiltrated, non-infiltrated, upper and lower PFM. The sEMG of 24 healthy women was also recorded for comparison. Four parameters were computed: root mean square (RMS), median frequency (MDF), Dimitrov’s index (DI) and sample entropy (SampEn). An index of pelvic electrophysiological impairment (IPEI) was also defined with respect to the healthy condition. Before treatment, the CPP and healthy parameters of almost all PFM sides were significantly different. Post-treatment, there was a significant reduction in power (<RMS), a shift towards higher frequencies (>MDF), lower fatigue index (<DI) and increased information complexity (>SampEn) in all sites in patients, mainly during PFM contractions, which brought their electrophysiological condition closer to that of healthy women (<IPEI). sEMG can be used to assess the PFM electrophysiological condition of CPP patients and the effects of therapies such as BoNT/A infiltration.
Open AccessEffect of BoNT/A in the Surface Electromyographic Characteristics of the Pelvic Floor Muscles for the Treatment of Chronic Pelvic Pain
Chronic pelvic pain (CPP) is a complex condition with a high economic and social burden. Although it is usually treated with botulinum neurotoxin type A (BoNT/A) injected into the pelvic floor muscles (PFM), its effect on their electrophysiological condition is unknown. In this study, 24 CPP patients were treated with BoNT/A. Surface electromyographic signals (sEMG) were recorded at Weeks 0 (infiltration), 8, 12 and 24 from the infiltrated, non-infiltrated, upper and lower PFM. The sEMG of 24 healthy women was also recorded for comparison. Four parameters were computed: root mean square (RMS), median frequency (MDF), Dimitrov’s index (DI) and sample entropy (SampEn). An index of pelvic electrophysiological impairment (IPEI) was also defined with respect to the healthy condition. Before treatment, the CPP and healthy parameters of almost all PFM sides were significantly different. Post-treatment, there was a significant reduction in power (<RMS), a shift towards higher frequencies (>MDF), lower fatigue index (<DI) and increased information complexity (>SampEn) in all sites in patients, mainly during PFM contractions, which brought their electrophysiological condition closer to that of healthy women (<IPEI). sEMG can be used to assess the PFM electrophysiological condition of CPP patients and the effects of therapies such as BoNT/A infiltration.
- Open Access
Characterization of Pelvic Floor Activity in Healthy Subjects and with Chronic Pelvic Pain: Diagnostic Potential of Surface Electromyography
Chronic pelvic pain (CPP) is a highly disabling disorder in women usually associated with hypertonic dysfunction of the pelvic floor musculature (PFM). The literature on the subject is not conclusive about the diagnostic potential of surface electromyography (sEMG), which could be due to poor signal characterization. In this study, we characterized the PFM activity of three groups of 24 subjects each: CPP patients with deep dyspareunia associated with a myofascial syndrome (CPP group), healthy women over 35 and/or parous (>35/P group, i.e., CPP counterparts) and under 35 and nulliparous (RMS), a predominance of low-frequency components (DI), greater complexity (>SampEn) and lower synchronization on the same side (35/P group. The same trend in differences was found between healthy women (35/P) associated with aging and parity. These results show that sEMG can reveal alterations in PFM electrophysiology and provide clinicians with objective information for CPP diagnosis.
Open AccessCharacterization of Pelvic Floor Activity in Healthy Subjects and with Chronic Pelvic Pain: Diagnostic Potential of Surface Electromyography
Chronic pelvic pain (CPP) is a highly disabling disorder in women usually associated with hypertonic dysfunction of the pelvic floor musculature (PFM). The literature on the subject is not conclusive about the diagnostic potential of surface electromyography (sEMG), which could be due to poor signal characterization. In this study, we characterized the PFM activity of three groups of 24 subjects each: CPP patients with deep dyspareunia associated with a myofascial syndrome (CPP group), healthy women over 35 and/or parous (>35/P group, i.e., CPP counterparts) and under 35 and nulliparous (RMS), a predominance of low-frequency components (DI), greater complexity (>SampEn) and lower synchronization on the same side (35/P group. The same trend in differences was found between healthy women (35/P) associated with aging and parity. These results show that sEMG can reveal alterations in PFM electrophysiology and provide clinicians with objective information for CPP diagnosis.
- Open Access
- 25 September 2019
- Published by Springer Nature
- p. 117-124
Non-invasive Intrauterine Pressure Estimation Based on Nonlinear Parameters Computed from the Electrohysterogram
- 25 September 2019
- Published by Springer Nature
- p. 117-124
Open AccessNon-invasive Intrauterine Pressure Estimation Based on Nonlinear Parameters Computed from the Electrohysterogram